5S9L
AUTOTAXIN, 4-[3-Oxo-3-(2-oxo-2,3-dihydro-benzooxazol-6-yl)-propyl]-piperazine-1-carboxylic acid 3,5-dichloro-benzyl ester, 1.90A, P212121, Rfree=19.1%
Summary for 5S9L
Entry DOI | 10.2210/pdb5s9l/pdb |
Group deposition | G_1002194 |
Descriptor | Isoform 2 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, ... (9 entities in total) |
Functional Keywords | hydrolase, lysophosphatidic acid, lpa, lysophosphatidylcholine, lpc, somatomedin, metastasis, neuropathic pain, vascular development, neural development |
Biological source | Rattus norvegicus (Rat) |
Total number of polymer chains | 1 |
Total formula weight | 99603.66 |
Authors | Stihle, M.,Hunziker, D.,Benz, J.,Mattei, P.,Rudolph, M.G. (deposition date: 2021-03-31, release date: 2022-04-13, Last modification date: 2024-04-03) |
Primary citation | Hunziker, D.,Joachim, S.C.,Ullmer, C.,Rudolph, M.G. Crystal Structure of a rat Autotaxin complex To be published, |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report